LER & CER: letter to Editor Rheumatology
Multiple testing in the ‘Canakinumab in atherosclerosis’ trial: correction required?
G. Guzelant1, Z. Ongen2
- Department of Internal Medicine, Division of Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey. guzelant_gul@hotmail.com
- Department of Cardiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
CER10337
2017 Vol.35, N°2 ,Suppl.104
PI 0024
LER & CER: letter to Editor Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 28516876 [PubMed]
Received: 17/02/2017
Accepted : 12/04/2017
In Press: 27/04/2017
Published: 29/05/2017


